[visionlist] $100,000 award for glaucoma research
cjohns at arvo.org
Tue Jul 25 15:02:08 -05 2017
The ARVO Foundation for Eye Research is accepting applications for the Dr. David L. Epstein Award.
Dr. Epstein, who passed away in March 2014, is widely considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 30 years. This award honors his commitment to the scientific understanding and treatment of glaucoma and will support promising clinician-scientists in furthering Dr. Epstein's investigation into solving the complex issues of glaucoma through well-conceived and executed scientific research focused on finding the causes and new treatments for the disease.
The Dr. David L. Epstein Award<http://www.arvo.org/foundation/Awards_and_Grants/Dr__David_L__Epstein_Award/?utm_medium=referral&utm_source=listserv&utm_campaign=epstein%20award> is given annually to a well-established, senior level investigator with documented history of conducting eye and vision research in glaucoma.
View<http://www.arvo.org/EpsteinAward-Application_Review/?utm_medium=referral&utm_source=listserv&utm_campaign=epstein%20award> the eligibility, criteria and general guidelines.
2018 Epstein Award timeline
Applications close: September 1, 2017
Recipients notified: November 2017
The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.
This email has been scanned for viruses and malware, and may have been automatically archived by Mimecast Ltd, an innovator in Software as a Service (SaaS) for business. Providing a safer and more useful place for your human generated data. Specializing in; Security, archiving and compliance. To find out more visit the Mimecast website.
-------------- next part --------------
An HTML attachment was scrubbed...
More information about the visionlist